Related Experiment Video
Updated: Jun 11, 2026

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
[Normal tissue tolerance to external beam radiation therapy: peripheral nerves].
B Henriques de Figueiredo1, A Huchet, C Dejean
1Département de Radiothérapie, Institut Bergonié, Centre Régional de Lutte Contre le Cancer, 229 Cours de l'Argonne, 33076 Bordeaux cedex, France. bhenriques@bergonie.org
Summary
Radiotherapy can cause delayed nerve damage, including plexopathies and peripheral neuropathies, particularly after breast, pelvic, or limb irradiation. Doses exceeding 50-60 Gy increase the risk of pain and other complications.
Area of Science:
- Oncology
- Neurology
- Radiation Oncology
Background:
- Radiotherapy can lead to delayed onset plexopathies and peripheral neuropathies.
- These nerve injuries are frequently observed following irradiation of the breast, pelvis, and limbs for various cancers.
- Peripheral nerves and plexuses are susceptible to radiation-induced damage, with dose being a critical factor.
Purpose of the Study:
- To review the occurrence and characteristics of radiation-induced nerve damage.
- To identify clinical situations and dose thresholds associated with plexopathies and peripheral neuropathies.
- To discuss factors influencing the risk of late radiation complications in nerves.
Main Methods:
- Literature review of studies on radiotherapy-induced nerve injuries.
- Analysis of clinical data regarding irradiation sites and doses.
- Examination of dose-response relationships and influencing factors.
Main Results:
- Nerve damage appears progressively years after radiotherapy, especially after breast, pelvic, and limb irradiation.
- A maximum tolerable dose threshold of 60 Gy is suggested, with significant pain occurrence differences between 50 and 60 Gy.
- Fractionation and high fraction doses influence the incidence of late radiation effects.
Conclusions:
- Radiotherapy dose, fractionation, and patient-specific factors (e.g., diabetes, vascular disease) are crucial in the development of late nerve complications.
- Understanding dose limits is essential for minimizing the risk of radiation-induced plexopathies and peripheral neuropathies.
- Further research is needed to refine dose constraints and management strategies for these debilitating side effects.